173 related articles for article (PubMed ID: 8269614)
1. Increased CYP1A2 content and capacity to activate Glu-P-1 and Trp-P-2 in liver microsomes of scorbutic ODS rats.
Mori T; Kitamura R; Imaoka S; Funae Y; Matsubara T; Kamataki T
Carcinogenesis; 1993 Dec; 14(12):2471-5. PubMed ID: 8269614
[TBL] [Abstract][Full Text] [Related]
2. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
3. Interspecies homology of cytochrome P-450: toxicological significance of cytochrome P-450 cross-reactive with anti-rat P-448-H antibodies in liver microsomes from dogs, monkeys and humans.
Ohta K; Kitada M; Ohi H; Komori M; Nagashima K; Sato N; Muroya K; Kodama T; Nagao M; Kamataki T
Mutat Res; 1989 Jul; 226(3):163-7. PubMed ID: 2501680
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats.
Sinclair PR; Gorman N; Sinclair JF; Walton HS; Bement WJ; Lambrecht RW
Hepatology; 1995 Aug; 22(2):565-72. PubMed ID: 7635426
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CYP1A and CYP3A mRNAs by ascorbic acid in guinea pigs.
Mori T; Itoh S; Ohgiya S; Ishizaki K; Kamataki T
Arch Biochem Biophys; 1997 Dec; 348(2):268-77. PubMed ID: 9434738
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs.
Kanazawa Y; Kitada M; Mori T; Inukai Y; Imaoka S; Funae Y; Kamataki T
Mol Pharmacol; 1991 Apr; 39(4):456-60. PubMed ID: 1901938
[TBL] [Abstract][Full Text] [Related]
8. Ascorbic acid deficiency reduces the level of mRNA for cytochrome P-450 on the induction by polychlorinated biphenyls.
Matsushita N; Kobayashi T; Oda H; Horio F; Yoshida A
J Nutr Sci Vitaminol (Tokyo); 1993 Aug; 39(4):289-302. PubMed ID: 8283309
[TBL] [Abstract][Full Text] [Related]
9. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
Kamataki T; Maeda K; Yamazoe Y; Matsuda N; Ishii K; Kato R
Mol Pharmacol; 1983 Jul; 24(1):146-55. PubMed ID: 6408394
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae.
Saner C; Weibel B; Wurgler FE; Sengstag C
Environ Mol Mutagen; 1996; 27(1):46-58. PubMed ID: 8625948
[TBL] [Abstract][Full Text] [Related]
11. Reactions of potent mutagens, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) with nucleic acid.
Hashimoto Y; Shudo K; Imamura M; Okamoto T
Nucleic Acids Symp Ser; 1980; (8):s109-12. PubMed ID: 7255181
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450.
Ishii K; Yamazoe Y; Kamataki T; Kato R
Chem Biol Interact; 1981 Dec; 38(1):1-13. PubMed ID: 6120046
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid.
Horio F; Ozaki K; Kohmura M; Yoshida A; Makino S; Hayashi Y
J Nutr; 1986 Nov; 116(11):2278-89. PubMed ID: 3098936
[TBL] [Abstract][Full Text] [Related]
15. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
16. The influence of thiamin deficiency on the metabolism of the oral contraceptive mestranol [3-methoxy-17-ethynyl-1,3,5(10)-estratrien-17 beta-o1] by female rat liver enzymes.
Wade AE; Evans JS
Steroids; 1977 Aug; 30(2):275-83. PubMed ID: 412282
[TBL] [Abstract][Full Text] [Related]
17. Examination for lipid peroxidation in liver microsomes of guinea pigs as a causal factor in the decrease in the content of cytochrome P-450 due to ascorbic acid deficiency.
Mori T; Kitamura R; Imaoka S; Funae Y; Kitada M; Kamataki T
Res Commun Chem Pathol Pharmacol; 1992 Feb; 75(2):209-19. PubMed ID: 1373902
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine by liver microsomes from three different rat strains.
Dragsted LO; Alexander J; Wallin H; Frandsen H; Vang O
Pharmacol Toxicol; 1993 Jun; 72(6):388-93. PubMed ID: 8361949
[TBL] [Abstract][Full Text] [Related]
19. Specificity of four forms of cytochrome P-450 in the metabolic activation of several aromatic amines and benzo[a]pyrene.
Yamazoe Y; Shimada M; Maeda K; Kamataki T; Kato R
Xenobiotica; 1984 Jul; 14(7):549-52. PubMed ID: 6438922
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
